共 50 条
- [41] Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
- [42] Evaluating the Utility of Patient-Identified Most Bothersome Symptom for Migraine Research [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 46 - 46
- [43] Evaluating the utility of patient-identified most bothersome symptom for migraine research [J]. HEADACHE, 2021, 61 : 126 - 127
- [45] Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences [J]. HEADACHE, 2018, 58 (09): : 1408 - 1426
- [47] Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine The ACHIEVE II Randomized Clinical Trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (19): : 1887 - 1898
- [50] Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome [J]. HEADACHE, 2021, 61 (05): : 766 - 776